This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,066.17 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,297.96 contract is a firm fixed-price delivery order for emtricitabine-tenofovir 200-300 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,509.19, is for the delivery of Emtricitabine-Tenofovir 200-300 mg tablets under Delivery Order SPE2DB24FH38V. The contract has a completion date of November 17, 2023 and is a Firm Fixed Price (FFP) contract type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $3,244.10. The contract is for the supply of Emtricitabine-Tenofovir 200-300 mg tablets, which are pharmaceutical products used for the treatment and prevention of HIV. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award is a delivery order between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $1,073.17, is for the supply of emtricitabine-tenofovir (200-300 mg) medications. The award is not designated with a set-aside requirement, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,096.64, is a Delivery Order contract for the procurement of Emtricitabine-Tenofovir 200-300mg medication, with a completion date of May 2, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,588.81 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 milligram drug dosages. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $1,098.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a specialty medication used to treat HIV. The award was made under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,210.20, is a delivery order contract for the supply of emtricitabine-tenofovir 200-300 mg pharmaceutical products. The contract has a completion date of May 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...